Evogene (TSE:EVGN – Free Report) had its price objective reduced by Pi Financial from C$5.00 to C$4.00 in a research note released on Wednesday, BayStreet.CA reports. Evogene Price Performance Evogene Company Profile (Get Free Report) Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including […]